Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet. On Nov. 11, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the drug is already approved, in different doses, for type 2 diabetes, as Mounjaro, and its effectiveness in those patients is due in part to its weight loss effects. [time-brightcove not-tgx=”true”] About 70% of Americans are overweight, with a body mass index (BMI) between 27 and 30, or obese, with a BMI over 30—which increase the risk of a host of oth
Hence then, the article about fda approves zepbound the most potent weight loss drug yet was published today ( ) and is available onTime ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet )